{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:51:26Z","timestamp":1775609486928,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Purpose:<\/jats:bold> Cuproptosis, a form of copper-induced cell death, can be a promising therapeutic target for refractory cancers. Hence, we conducted this research to explore the association between cuproptosis and prognosis in cervical cancer (CC).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> For constructing a prognostic signature based on cuproptosis-related genes from TCGA database, the least absolute shrinkage and selection operator Cox regression was utilized. The GSE44001 cohort was utilized for validation.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of nine cuproptosis-related genes showed distinct expression in CC and normal samples in TCGA-GTEx cohort. Two risk groups were identified based on a seven-gene signature. A significant decrease in overall survival was observed in the high-risk group (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). The risk score (HR = 2.77, 95% CI = 1.58\u20134.86) was an autocephalous predictor with a better predictive ability than the clinical stage. Functional analysis indicated that immune activities were suppressed more in the high-risk group than in the low-risk group. A total of 11 candidate compounds targeting the signature were identified.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> A total of seven cuproptosis-related gene signatures were constructed to predict prognosis and propose a new therapeutic target for patients with CC.<\/jats:p>","DOI":"10.3389\/fgene.2022.957744","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T08:12:11Z","timestamp":1661415131000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Lei","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15399","DOI":"10.1038\/s41598-018-33677-4","article-title":"GCSH antisense regulation determines breast cancer cells' viability","volume":"8","author":"Adamus","year":"2018","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.semcancer.2021.05.023","article-title":"Interference between copper transport systems and platinum drugs","volume":"76","author":"Arnesano","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","article-title":"Wilson's disease and other neurological copper disorders","volume":"14","author":"Bandmann","year":"2015","journal-title":"Lancet. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/biomedicines9111628","article-title":"Blood copper levels and the occurrence of colorectal cancer in Poland","author":"Baszuk","year":"2021","journal-title":"Biomedicines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41588-017-0026-3","article-title":"Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"LANCET"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","article-title":"Wilson disease","volume":"4","author":"Czlonkowska","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41419-018-0494-0","article-title":"PGC1\u03b1 promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect.","volume":"9","author":"Dan","year":"2018","journal-title":"Cell Death Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1158\/1078-0432.CCR-20-2833","article-title":"Cervical cancer immunotherapy: Facts and hopes","volume":"27","author":"Ferrall","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1002\/1878-0261.13079","article-title":"Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A","volume":"15","author":"Gao","year":"2021","journal-title":"Mol. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","article-title":"Connecting copper and cancer: From transition metal signalling to metalloplasia","volume":"22","author":"Ge","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"B12","first-page":"1140","article-title":"DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy","volume":"7","author":"Goh","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","article-title":"Elevated copper and oxidative stress in cancer cells as a target for cancer treatment","volume":"35","author":"Gupte","year":"2009","journal-title":"CANCER Treat. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nri.2017.146","article-title":"Epigenetic control of CD8(+) T cell differentiation","volume":"18","author":"Henning","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1172\/JCI129338","article-title":"Killers 2.0: NK cell therapies at the forefront of cancer control","volume":"129","author":"Hodgins","year":"2019","journal-title":"J. Clin. Invest.."},{"key":"B17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ccr.2010.04.011","article-title":"Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator","volume":"17","author":"Ishida","year":"2010","journal-title":"CANCER Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"djx030","DOI":"10.1093\/jnci\/djx030","article-title":"Annual report to the nation on the status of cancer, 1975-2014, featuring survival","volume":"109","author":"Jemal","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.abo3959","article-title":"Copper-induced cell death","volume":"375","author":"Kahlson","year":"2022","journal-title":"SCIENCE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00535-004-1466-y","article-title":"Recent clinical features of Wilson's disease with hepatic presentation","volume":"39","author":"Kumagi","year":"2004","journal-title":"J. Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B22","first-page":"2076","article-title":"Decreased expression of pyruvate dehydrogenase A1 predicts an unfavorable prognosis in ovarian carcinoma","volume":"6","author":"Li","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1158\/1078-0432.CCR-20-2564","article-title":"Type I IFN activating type I dendritic cells for antitumor immunity","volume":"27","author":"Liang","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.clnu.2020.10.011","article-title":"Ovarian cancer risk according to circulating zinc and copper concentrations: A meta-analysis and mendelian randomization study","volume":"40","author":"Lin","year":"2021","journal-title":"Clin. Nutr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ygyno.2018.10.001","article-title":"A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology\/gynecologic oncology group study","volume":"151","author":"Monk","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1200\/JCO.2012.44.5585","article-title":"Final results of phase III SYMMETRY study: Randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma","volume":"31","author":"O'Day","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/cells8060622","article-title":"Human papilloma virus-associated cervical cancer and health disparities","volume":"8","author":"Olusola","year":"2019","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"LANCET"},{"key":"B29","first-page":"5853","article-title":"Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients","volume":"9","author":"Samimi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.molcel.2014.06.020","article-title":"Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth","volume":"55","author":"Shan","year":"2014","journal-title":"Mol. Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6836","DOI":"10.1073\/pnas.1817473116","article-title":"ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis","volume":"116","author":"Shanbhag","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"Ca. Cancer J. Clin."},{"key":"B33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.prp.2018.12.038","article-title":"Low expression of PDHA1 predicts poor prognosis in gastric cancer","volume":"215","author":"Song","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"B34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","article-title":"Apoptosis, autophagy, necroptosis, and cancer metastasis","volume":"14","author":"Su","year":"2015","journal-title":"Mol. Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca. Cancer J. Clin."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.3748\/wjg.v19.i13.2110","article-title":"Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease","volume":"19","author":"Thattil","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"SCIENCE"},{"key":"B38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","article-title":"Mitochondrial metabolism promotes adaptation to proteotoxic stress","volume":"15","author":"Tsvetkov","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s005350200065","article-title":"Molecular cloning, and characterization and expression of dihydrolipoamide acetyltransferase component of murine pyruvate dehydrogenase complex in bile duct cancer cells","volume":"37","author":"Wang","year":"2002","journal-title":"J. Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1111\/cas.15137","article-title":"FGF13 enhances resistance to platinum drugs by regulating hCTR1 and ATP7A via a microtubule-stabilizing effect","volume":"112","author":"Yu","year":"2021","journal-title":"Cancer Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"BSR20180161","DOI":"10.1042\/BSR20180161","article-title":"Association between serum copper levels and cervical cancer risk: A meta-analysis","author":"Zhang","year":"2018","journal-title":"Biosci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"749134","DOI":"10.3389\/fphar.2021.749134","article-title":"FDX1 can impact the prognosis and mediate the metabolism of lung adenocarcinoma","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.957744\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T08:12:17Z","timestamp":1661415137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.957744\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":42,"alternative-id":["10.3389\/fgene.2022.957744"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.957744","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"957744"}}